Partnerships with Dress for Success and The Skin Cancer Foundation Provide an Opportunity to Give Back with Each Dysport®* (abobotulinumtoxinA) for Injection Treatment
December 8, 2021 (Fort Worth, TX) – Galderma, the world’s leading dermatology company, is pleased to announce the relocation of its U.S. headquarters to downtown Dallas. In summer 2022, Galderma will relocate to the Trammell Crow Center at 2001 Ross Ave. Galderma has approximately 400 home office employees who will work from the new location.
Galderma will present a wealth of data including new findings showing the impact of modern living on sensitive skin and insights from the largest global survey conducted on the condition
Late-breaking data on Nemluvio’s® (nemolizumab) mode of action in atopic dermatitis (AD) and long-term safety and efficacy data in prurigo nodularis (PN) and mod
